SurExam Bio-Tech has a total of 368 patents globally, out of which 272 have been granted. Of these 368 patents, more than 61% patents are active. China is where SurExam Bio-Tech has filed the maximum number of patents, followed by United States of America and Europe (EPO). Parallelly, China seems to be the main focused R&D centre and also is the origin country of SurExam Bio-Tech.
SurExam Bio-Tech was founded in 2006. SurExam Bio-Tech specializes in developing, manufacturing, and promoting personalized medical testing products for cancer diagnosis and treatment.
Do read about some of the most popular patents of SurExam Bio-Tech which have been covered by us in this article and also you can find SurExam Bio-Tech patents information, the worldwide patent filing activity and its patent filing trend over the years, and many other stats over SurExam Bio-Tech patent portfolio.
How many patents does SurExam Bio-Tech have?
SurExam Bio-Tech has a total of 368 patents globally. These patents belong to 350 unique patent families. Out of 368 patents, 227 patents are active.
How Many Patents did SurExam Bio-Tech File Every Year?
Are you wondering why there is a drop in patent filing for the last two years? It is because a patent application can take up to 18 months to get published. Certainly, it doesn’t suggest a decrease in the patent filing.
| Year of Patents Filing or Grant | SurExam Bio-Tech Applications Filed | SurExam Bio-Tech Patents Granted |
| 2023 | 1 | 7 |
| 2022 | 6 | 10 |
| 2021 | 4 | 9 |
| 2020 | 14 | 32 |
| 2019 | 24 | 19 |
| 2018 | 23 | 13 |
| 2017 | 22 | 3 |
| 2016 | 26 | 24 |
| 2015 | 32 | 22 |
| 2014 | 11 | 61 |
How many SurExam Bio-Tech patents are Alive/Dead?
Worldwide Patents
How Many Patents did SurExam Bio-Tech File in Different Countries?
Countries in which SurExam Bio-Tech Filed Patents
| Country | Patent |
| China | 349 |
| United States of America | 4 |
| Europe (EPO) | 4 |
| Austria | 1 |
| Germany | 1 |
Where are Research Centers of SurExam Bio-Tech Patents Located?
10 Best SurExam Bio-Tech Patents
CN109022417A is the most popular patent in the SurExam Bio-Tech portfolio. It has received 33 citations so far from companies like Company, Research, Mcafee.
Below is the list of 10 most cited patents of SurExam Bio-Tech:
| Publication Number | Citation Count |
| CN109022417A | 33 |
| CN101271108A | 23 |
| CN101571545A | 21 |
| CN110305940A | 14 |
| CN104561361A | 14 |
| US20110269640A1 | 10 |
| CN104178424A | 10 |
| CN110923320A | 8 |
| CN108048566A | 8 |
| CN105316398A | 8 |
What Percentage of SurExam Bio-Tech US Patent Applications Were Granted?
SurExam Bio-Tech (Excluding its subsidiaries) has filed 4 patent applications at USPTO so far (Excluding Design and PCT applications). Out of these 1 have been granted leading to a grant rate of 100%.
Below are the key stats of SurExam Bio-Tech patent prosecution at the USPTO.
Which Law Firms Filed Most US Patents for SurExam Bio-Tech?
| Law Firm | Total Applications | Success Rate |
| Lerner David Llp | 4 | 25% |
What are SurExam key innovation segments?
What Technologies are Covered by SurExam ?
The chart below distributes patents filed by SurExam in different countries on the basis of the technology protected in patents. It also represents the markets where SurExam thinks it’s important to protect particular technology inventions.
R&D Focus: How has SurExam search focus changed over the years?
EXCLUSIVE INSIGHTS COMING SOON!
Interested in knowing about the areas of innovation that are being protected by SurExam?